195 related articles for article (PubMed ID: 30897575)
1. Interferon-Beta Treatment Differentially Alters TLR2 and TLR4-Dependent Cytokine Production in Multiple Sclerosis Patients.
Oliveira IBN; Gomes RS; Gomides LF; Dos Santos JC; Carneiro MAD; Ribeiro-Dias F; Diniz DS
Neuroimmunomodulation; 2019; 26(2):77-83. PubMed ID: 30897575
[TBL] [Abstract][Full Text] [Related]
2. Synergism of toll-like receptor 2 (TLR2), TLR4, and TLR6 ligation on the production of tumor necrosis factor (TNF)-alpha in a spontaneous arthritis animal model of interleukin (IL)-1 receptor antagonist-deficient mice.
Jung YO; Cho ML; Lee SY; Oh HJ; Park JS; Park MK; Park MJ; Ju JH; Kim SI; Park SH; Kim HY; Min JK
Immunol Lett; 2009 Apr; 123(2):138-43. PubMed ID: 19428561
[TBL] [Abstract][Full Text] [Related]
3. The involvement of TLR2 and TLR4 in cytokine and nitric oxide production in visceral leishmaniasis patients before and after treatment with anti-leishmanial drugs.
Gatto M; de Abreu MM; Tasca KI; de Assis Golim M; da Silva LD; Simão JC; Fortaleza CM; de Campos Soares ÂM; Calvi SA
PLoS One; 2015; 10(2):e0117977. PubMed ID: 25706930
[TBL] [Abstract][Full Text] [Related]
4. Dectin-1 synergizes with TLR2 and TLR4 for cytokine production in human primary monocytes and macrophages.
Ferwerda G; Meyer-Wentrup F; Kullberg BJ; Netea MG; Adema GJ
Cell Microbiol; 2008 Oct; 10(10):2058-66. PubMed ID: 18549457
[TBL] [Abstract][Full Text] [Related]
5. [T-cell interferon-gamma, tumor necrosis factor-alpha and interleukin-6 receptor binding in patients with multiple sclerosis. Effects of interferon-beta-1b treatment].
Bongioanni P; Romano MR; Boccardi B; Lombardo F; Moscato G; Mosti S; Baldini C; Nuti S; Meucci G; Rossi B
Rev Neurol; 1999 Nov 16-30; 29(10):893-9. PubMed ID: 10637835
[TBL] [Abstract][Full Text] [Related]
6. Effects of budesonide on toll-like receptor expression in alveolar macrophages from smokers with and without COPD.
Ji J; von Schéele I; Billing B; Dahlén B; Lantz AS; Larsson K; Palmberg L
Int J Chron Obstruct Pulmon Dis; 2016; 11():1035-43. PubMed ID: 27274225
[TBL] [Abstract][Full Text] [Related]
7. Reduced production of noggin by immune cells of patients with relapsing-remitting multiple sclerosis.
Urshansky N; Mausner-Fainberg K; Auriel E; Regev K; Bornstein NM; Karni A
J Neuroimmunol; 2011 Mar; 232(1-2):171-8. PubMed ID: 21111488
[TBL] [Abstract][Full Text] [Related]
8. Multiple sclerosis is associated with an imbalance between tumour necrosis factor-alpha (TNF-alpha)- and IL-10-secreting blood cells that is corrected by interferon-beta (IFN-beta) treatment.
Ozenci V; Kouwenhoven M; Huang YM; Kivisäkk P; Link H
Clin Exp Immunol; 2000 Apr; 120(1):147-53. PubMed ID: 10759776
[TBL] [Abstract][Full Text] [Related]
9. Significance of toll-like receptors 2 and 4 mRNA expression in chronic hepatitis C virus infection.
Shehata MA; Abou El-Enein A; El-Sharnouby GA
Egypt J Immunol; 2006; 13(1):141-52. PubMed ID: 17974158
[TBL] [Abstract][Full Text] [Related]
10. Implication of the Toll-like receptor 4 pathway in the response to interferon-β in multiple sclerosis.
Bustamante MF; Fissolo N; Río J; Espejo C; Costa C; Mansilla MJ; Lizasoain I; Moro MA; Carmen Edo M; Montalban X; Comabella M
Ann Neurol; 2011 Oct; 70(4):634-45. PubMed ID: 22028223
[TBL] [Abstract][Full Text] [Related]
11. Interferon-beta 1b treatment decreases tumor necrosis factor-alpha and increases interleukin-6 production in multiple sclerosis.
Brod SA; Marshall GD; Henninger EM; Sriram S; Khan M; Wolinsky JS
Neurology; 1996 Jun; 46(6):1633-8. PubMed ID: 8649562
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of toll-like receptors 2 and 4 and related cytokines in persistent allergic rhinitis.
Cui XY; Chen X; Yu CJ; Yang J; Lin ZP; Yin M; Cheng L
Otolaryngol Head Neck Surg; 2015 Feb; 152(2):233-8. PubMed ID: 25505260
[TBL] [Abstract][Full Text] [Related]
13. Multiple sclerosis: expression of CD1a and production of IL-12p70 and IFN-gamma by blood mononuclear cells in patients on combination therapy with IFN-beta and glatiramer acetate compared to monotherapy with IFN-beta.
Hussien Y; Sanna A; Söderström M; Link H; Huang YM
Mult Scler; 2004 Feb; 10(1):16-25. PubMed ID: 14760948
[TBL] [Abstract][Full Text] [Related]
14. Oral terbutaline differentially affects cytokine (IL-10, IL-12, TNF, IFNg) release in multiple sclerosis patients and controls.
Heesen C; Gold SM; Sondermann J; Tessmer W; Schulz KH
J Neuroimmunol; 2002 Nov; 132(1-2):189-95. PubMed ID: 12417450
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor 4 and Toll-IL-1 receptor domain-containing adapter protein (TIRAP)/myeloid differentiation protein 88 adapter-like (Mal) contribute to maximal IL-6 expression in macrophages.
Schilling D; Thomas K; Nixdorff K; Vogel SN; Fenton MJ
J Immunol; 2002 Nov; 169(10):5874-80. PubMed ID: 12421970
[TBL] [Abstract][Full Text] [Related]
16. Ability of supragingival plaque to induce toll-like receptor 4-mediated stimulation is associated with cytokine production by peripheral blood mononuclear cells.
Yamaguchi R; Yoshimura A; Yoshioka H; Kaneko T; Hara Y
J Periodontol; 2009 Mar; 80(3):512-20. PubMed ID: 19254136
[TBL] [Abstract][Full Text] [Related]
17. Signaling via toll-like receptor 4 and CD40 in B cells plays a regulatory role in the pathogenesis of multiple sclerosis through interleukin-10 production.
Okada Y; Ochi H; Fujii C; Hashi Y; Hamatani M; Ashida S; Kawamura K; Kusaka H; Matsumoto S; Nakagawa M; Mizuno T; Takahashi R; Kondo T
J Autoimmun; 2018 Mar; 88():103-113. PubMed ID: 29146546
[TBL] [Abstract][Full Text] [Related]
18. TLR2 and TLR4 expression in peripheral blood mononuclear cells of patients with chronic cystic echinococcosis and its relationship with IL-10.
Shan JY; Ji WZ; Li HT; Tuxun T; Lin RY; Wen H
Parasite Immunol; 2011 Dec; 33(12):692-6. PubMed ID: 21923667
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporine and tacrolimus have inhibitory effects on toll-like receptor signaling after liver transplantation.
Howell J; Sawhney R; Testro A; Skinner N; Gow P; Angus P; Ratnam D; Visvanathan K
Liver Transpl; 2013 Oct; 19(10):1099-107. PubMed ID: 23894100
[TBL] [Abstract][Full Text] [Related]
20. Increased IL-10 mRNA and IL-23 mRNA expression in multiple sclerosis: interferon-beta treatment increases IL-10 mRNA expression while reducing IL-23 mRNA expression.
Krakauer M; Sorensen P; Khademi M; Olsson T; Sellebjerg F
Mult Scler; 2008 Jun; 14(5):622-30. PubMed ID: 18424480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
